MarketInOut Stock Screener Log In | Sign Up

Castle Biosciences Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Castle Biosciences Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,135.22 mln
Float29.94 mln
Earnings Date11/05/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.94
Likely reliable

1-Year Forecast

46.70
Strong upside

Relative Strength

96 / 100
Top performer

Debt / Equity

0.08
Debt-free

Pre-Tax Margin

-5%
Marginally loss-making

Business Description

Castle Biosciences is a medical testing company that uses gene analysis to help doctors make better treatment decisions for patients with skin cancers, esophageal conditions, and related diseases. Its portfolio of proprietary tests helps predict how a patient's condition may progress, identify difficult-to-diagnose cases, and guide the selection of appropriate therapies. Founded in 2007 and based in Friendswood, Texas, the company primarily serves dermatology and gastroenterology specialists across the United States.

Key Fundamentals

EPS-0.64
ROE-4.18
RPS12.04
ROIC-12.04
ROA-3.44
Interest Cover-85.62
EBITDA, mln-3.24
EV / EBITDA-254
EV / EBIT-43.63
Revenue, mln357
EV / Revenue2.30

Quote Details

Last 37.16
Change -1.35 (-3.51%)
Open 38.03
Volume 334,258
Turnover 12,421,027
Average Volume 339,411

Financial Ratios

Pre-Tax Profit Margin-5
Leverage Ratio1.19
Current Ratio6.04
Price / Book2.24
Price / Tangible Book2.81
Price / Cash Flow26.50
Debt / Equity0.08
Price / Sales2.87

Financial Strength

Altman Z-Score7.47
Piotroski F-Score 4 / 9
Beneish M-Score-2.94
1-Year Target Price46.70
Short Ratio5.17
Short % of Float6.76

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.33% 95 / 100   
1 Month 5.39% 86 / 100   
2 Months 52.05% 97 / 100   
6 Months 49.78% 96 / 100   
1 Year 56.53% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog